Search Results - "Aleixo, Sabina B."
-
1
A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer
Published in Clinical breast cancer (01-04-2015)“…Micro-Abstract Neoadjuvant therapy is used to shrink tumors to facilitate surgery. In this phase II neoadjuvant trial we compared the efficacy and safety of…”
Get full text
Journal Article -
2
Post pandemic reality in breast cancer in Brazil
Published in Journal of clinical oncology (01-06-2023)“…e22530 Background: After the coronavirus disease 2019 (COVID-19) pandemic, there was impact in breast cancer diagnosis all over the world but especially in low…”
Get full text
Journal Article -
3
Lethality of lung cancer in southeast of Brazil: Real-world data
Published in Journal of clinical oncology (01-06-2022)“…e22515 Background: Lung Cancer (LC) is one of the most common neoplasm of all malignant tumors, with an increasing lethality and incidence, corresponding to…”
Get full text
Journal Article -
4
Social disparities in Southeastern Brazil and the burden of cervical cancer
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e18511 Background: Cervical cancer (CC) is the fourth most common malignancy in women worldwide and around 85% of the cases currently diagnosed…”
Get full text
Journal Article -
5
The present scenario of colorectal cancer in Southeastern Brazil
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e18782 Background: Cancer is the second leading cause of death in the world and in Brazil. Most of colorectal cancers (CRC) are sporadic and…”
Get full text
Journal Article -
6
Breast cancer and molecular testing in Brazil
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e13602 Background: Breast cancer is a common malignancy among women worldwide. Regardless of the economic status of a country, breast cancer…”
Get full text
Journal Article -
7
Lack of organization to access cancer treatment in southeast Brazil: Urgent need to change
Published in Journal of clinical oncology (01-06-2023)“…e18516 Background: Healthcare access is a fundamental component in achieving universal health coverage, the central commitment of the Brazilian Unified Health…”
Get full text
Journal Article -
8
Lung cancer incidence in never smokers in the Southeast of Brazil: 10 years analysis
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e13571 Background: Lung cancer is a leading cause of cancer death worldwide. In Brazil, the Ministry of Health estimated an absolute incidence of…”
Get full text
Journal Article -
9
Breast cancer in younger patients in Southeast of Brazil: 10-year analysis
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e13567 Background: Breast cancer in Brazil is the most common cancer among women and is also responsible for the highest number of cancer deaths…”
Get full text
Journal Article -
10
Profile of cancer patients admitted in a emergency room of a charity hospital in Southeast Brazil
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e19307 Background: Given the increase in cancer cases worlwide, there has been a high demand for urgent and emergency care by oncologic patients…”
Get full text
Journal Article -
11
Lung clinical trials and access to molecular markers in a small, low-income city in Brazil
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
12
Management of breast cancer in a small Charity Hospital Cancer Center in Brazil: Ten years of a single institution´s experience
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
13
Experience of a small cancer center from Brazil with implantable port systems in the brachial veins
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
14
A neoadjuvant, randomized, open-label phase II trial of afatinib (A) versus trastuzumab (T) versus lapatinib (L) in patients (pts) with locally advanced HER2-positive breast cancer (BC)
Published in Journal of clinical oncology (20-05-2012)“…Abstract only 606 Background: A is an oral, irreversible, ErbB Family Blocker. This Phase II study investigated A, L and T monotherapy in pts with locally…”
Get full text
Journal Article